VIVE.ST
Price:
$8.99
Market Cap:
$48.36M
Vivesto AB, established in 1988 and headquartered in Solna, Sweden, specializes in the development, production, commercialization, and sale of pharmaceutical products within human and veterinary oncology, primarily operating in its home country. Its leading human oncology product is Apealea (paclitaxel micellar), designed for the treatment of ovarian cancer. The company's pipeline for human health also includes Docetaxel micellar, a patented formulation combining the cytotoxin docetaxel with XR-17, which is currently in Phase 1b clinical trials for prostate cancer, as well as Cantrixil for addressing ovarian cancer. For animal health, Vivesto provides Paccal Vet, leveraging its XR-17 encapsu...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-06-24
Stock Exchange
STO
Ticker
VIVE.ST
According to Vivesto AB’s latest financial reports and current stock price. The company's current PE Ratio is -165.87. This represents a change of -44.13% compared to the average of -296.88 of the last 4 quarters.
The mean historical PE Ratio of Vivesto AB over the last ten years is -5091.70. The current -165.87 PE Ratio has changed 225.77% with respect to the historical average. Over the past ten years (40 quarters), VIVE.ST's PE Ratio was at its highest in in the April 2020 quarter at 782.81. The PE Ratio was at its lowest in in the December 2021 quarter at -10929.17.
Average
-5091.70
Median
-704.68
Minimum
-28465.91
Maximum
-58.65
Discovering the peaks and valleys of Vivesto AB PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.91%
Maximum Annual PE Ratio = -58.65
Minimum Annual Increase = -95.36%
Minimum Annual PE Ratio = -28465.91
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -213.25 | -45.66% |
| 2024 | -392.42 | 569.11% |
| 2022 | -58.65 | -93.07% |
| 2021 | -846.13 | -95.36% |
| 2020 | -18230.09 | -35.96% |
| 2020 | -28465.91 | 3.91% |
| 2019 | -709.28 | 1.31% |
| 2018 | -700.09 | 66.14% |
| 2017 | -421.38 | -52.11% |
| 2016 | -879.83 | -43.70% |
The current PE Ratio of Vivesto AB (VIVE.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-221.44
5-year avg
-3948.11
10-year avg
-5091.70
Vivesto AB’s PE Ratio is less than AcuCort AB (-4.36), less than SciBase Holding AB (publ) (-1.28), less than Nanologica AB (publ) (1.74), less than Klaria Pharma Holding AB (publ.) (-3.62), less than Xbrane Biopharma AB (publ) (-3.99), less than Scandinavian ChemoTech AB (publ) (-14.45), greater than Active Biotech AB (-224.35), less than Arcoma AB (32.43), less than Biovica International AB (publ) (-1.48), less than Immunovia AB (-0.98),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.36 | $143.01M | |
| -1.28 | $275.06M | |
| 1.74 | $154.19M | |
| -3.62 | $226.30M | |
| -3.99 | $116.39M | |
| -14.45 | $87.35M | |
| -224.35 | $136.02M | |
| 32.43 | $122.77M | |
| -1.48 | $147.07M | |
| -0.98 | $56.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivesto AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vivesto AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vivesto AB's PE Ratio?
How is the PE Ratio calculated for Vivesto AB (VIVE.ST)?
What is the highest PE Ratio for Vivesto AB (VIVE.ST)?
What is the 3-year average PE Ratio for Vivesto AB (VIVE.ST)?
What is the 5-year average PE Ratio for Vivesto AB (VIVE.ST)?
How does the current PE Ratio for Vivesto AB (VIVE.ST) compare to its historical average?